While IL-36, IL-37, and IL-38 have been broadly investigated in both osteoarthritis (OA) and RA (14), this review examines IL-37 and IL-38 in RA more specifically, highlighting their emerging roles and therapeutic promise (Figure 1). The gene discussed is IL37; the disease is rheumatoid arthritis.